A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 21,540 shares of ABT stock, worth $2.47 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
21,540
Previous 21,540 -0.0%
Holding current value
$2.47 Million
Previous $2.24 Million 9.7%
% of portfolio
0.86%
Previous 0.85%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$100.73 - $112.44 $128,027 - $142,911
1,271 Added 6.27%
21,540 $2.24 Million
Q1 2024

Apr 23, 2024

SELL
$109.52 - $120.96 $81,811 - $90,357
-747 Reduced 3.55%
20,269 $2.3 Million
Q4 2023

Jan 18, 2024

SELL
$90.19 - $110.4 $1.95 Million - $2.38 Million
-21,597 Reduced 50.68%
21,016 $2.31 Million
Q3 2023

Oct 13, 2023

SELL
$95.53 - $114.62 $19,106 - $22,924
-200 Reduced 0.47%
42,613 $4.13 Million
Q1 2023

Apr 17, 2023

BUY
$96.86 - $114.01 $96 - $114
1 Added 0.0%
42,813 $4.34 Million
Q4 2022

Feb 01, 2023

SELL
$95.06 - $111.52 $20,628 - $24,199
-217 Reduced 0.5%
42,812 $4.7 Million
Q3 2022

Oct 12, 2022

SELL
$96.76 - $112.03 $2,419 - $2,800
-25 Reduced 0.06%
43,029 $4.16 Million
Q2 2022

Jul 20, 2022

BUY
$102.07 - $123.37 $9,594 - $11,596
94 Added 0.22%
43,054 $4.68 Million
Q1 2022

Apr 29, 2022

SELL
$114.02 - $139.04 $75,253 - $91,766
-660 Reduced 1.51%
42,960 $5.09 Million
Q3 2021

Oct 21, 2021

SELL
$116.66 - $129.06 $30,331 - $33,555
-260 Reduced 0.59%
43,620 $5.18 Million
Q2 2021

Jul 23, 2021

SELL
$105.79 - $124.53 $1.28 Million - $1.51 Million
-12,100 Reduced 21.61%
43,880 $5.09 Million
Q1 2021

Apr 22, 2021

SELL
$108.84 - $128.23 $3,156 - $3,718
-29 Reduced 0.05%
55,980 $6.71 Million
Q4 2020

Feb 01, 2021

SELL
$105.0 - $114.42 $5,250 - $5,721
-50 Reduced 0.09%
56,009 $6.13 Million
Q3 2020

Oct 14, 2020

SELL
$91.64 - $111.29 $43,070 - $52,306
-470 Reduced 0.83%
56,059 $6.1 Million
Q2 2020

Jul 24, 2020

SELL
$76.57 - $98.0 $2,067 - $2,646
-27 Reduced 0.05%
56,529 $5.17 Million
Q1 2020

Apr 16, 2020

SELL
$62.82 - $91.86 $54,150 - $79,183
-862 Reduced 1.5%
56,556 $4.46 Million
Q4 2019

Jan 29, 2020

SELL
$78.51 - $87.4 $26,065 - $29,016
-332 Reduced 0.57%
57,418 $4.99 Million
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $59,579 - $64,602
-728 Reduced 1.24%
57,750 $4.83 Million
Q2 2019

Jul 22, 2019

SELL
$72.88 - $85.0 $115,660 - $134,895
-1,587 Reduced 2.64%
58,478 $4.92 Million
Q1 2019

Apr 19, 2019

SELL
$66.22 - $80.06 $70,524 - $85,263
-1,065 Reduced 1.74%
60,065 $4.8 Million
Q4 2018

Feb 06, 2019

BUY
$65.56 - $74.27 $2,753 - $3,119
42 Added 0.07%
61,130 $4.42 Million
Q3 2018

Oct 26, 2018

SELL
$60.81 - $73.36 $58,742 - $70,865
-966 Reduced 1.56%
61,088 $4.48 Million
Q2 2018

Aug 03, 2018

SELL
$57.57 - $63.54 $36,269 - $40,030
-630 Reduced 1.01%
62,054 $3.78 Million
Q1 2018

Apr 25, 2018

SELL
$56.27 - $63.62 $17,049 - $19,276
-303 Reduced 0.48%
62,684 $3.76 Million
Q4 2017

Apr 05, 2018

BUY
$53.68 - $57.47 $3.38 Million - $3.62 Million
62,987
62,987 $3.59 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cornell Pochily Investment Advisors, Inc. Portfolio

Follow Cornell Pochily Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornell Pochily Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornell Pochily Investment Advisors, Inc. with notifications on news.